SCHEMBL7863427

SCHEMBL7863427

O=C(CBr)c1ccccc1[C](c1ccccc1)c1ccccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.52
PTPN1 P18031 3/20 0.52
ALDH1A1 P00352 3/20 0.47
ERCC5 P28715 1/20 0.46
FEN1 P39748 1/20 0.46
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
SMO Q99835 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
GAA P10253 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
MAPT P10636 1/20 0.41
POLB P06746 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38141 0.82 ERCC5 (0.58) GSK3BPTPN1ALDH1A1ERCC5FEN1
SCHEMBL29621373 0.82 ERCC5 (0.58) GSK3BPTPN1ALDH1A1ERCC5FEN1
Bromide SCHEMBL235266 0.81 ERCC5 (0.56) GSK3BPTPN1ALDH1A1ERCC5FEN1
SCHEMBL374630 0.80 ALDH1A1 (0.56) ALDH1A1ERCC5FEN1CES2CES1
SCHEMBL33952 0.76 ALDH1A1 (0.56) ALDH1A1ERCC5FEN1CES2CES1
SCHEMBL9409754 0.76 PTPN1 (0.65) GSK3BPTPN1ALDH1A1CES1SMN1; SMN2
SCHEMBL17376015 0.75 ERCC5 (0.56) GSK3BPTPN1ALDH1A1ERCC5FEN1
SCHEMBL28317790 0.74 ALDH1A1 (0.54) ALDH1A1ERCC5FEN1CES2CES1
SCHEMBL31519376 0.73 ALDH1A1 (0.64) GSK3BPTPN1ALDH1A1SMN1; SMN2HPGD
SCHEMBL1893853 0.73 ALDH1A1 (0.64) GSK3BPTPN1ALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300321-B1 LIPOPOLYAMINES AVENTIS PHARMA S.A. (FR) 2001-10-09 US disclosed